youtube_live
Q3 2026 earnings • released • EPS miss -14,29%
See resultschevron_right
AARD:NASDAQ
Aardvark Therapeutics Inc
1,26 $
arrow_downward
-5,26%(-0,070) 1D
1,21 $
arrow_downward
-4,22% (-0,053)bedtimeAfter hours
Closed: 16 қар., 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AARD...
Open
1,33 $
High
1,48 $
Low
1,21 $
Mkt. cap
27,57 млн
Avg. vol.
1,20 млн
Volume
0,00
52-wk high
16,60 $
52-wk low
0,93 $
EPS
-3,21 $
Shares outstanding
21,88 млн
No. of employees
28
Open
1,33 $
High
1,48 $
Low
1,21 $
Mkt. cap
27,57 млн
Avg. vol.
1,20 млн
Volume
0,00
52-wk high
16,60 $
52-wk low
0,93 $
EPS
-3,21 $
Shares outstanding
21,88 млн
No. of employees
28
News stories
From web sources and news partners
Investing.com Canada
·
16 сағат бұрын
Stifel cuts Aardvark Therapeutics stock price target on FDA uncertainty By Investing.com
AlphaStreet
·
3 күн бұрын
Aardvark Therapeutics Releases Q3 2026 Financial Results
About Aardvark Therapeutics Inc
CEO-
Employees28
Founded2017
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteaardvarktherapeutics.com